Novavax (NVAX) Misses Q1 EPS by 13c; Offers FY22 Revenue Guidance
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.17 +8.77%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
ALZN, ASPU, USAU, More
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of $2.56, $0.13 worse than the analyst estimate of $2.69. Revenue for the quarter came in at $704 million versus the consensus estimate of $845.2 million.
GUIDANCE:
Novavax sees FY2022 revenue of $4-5 billion.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Empress Royalty acquires Tongon gold stream for $62M
- Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
